Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy

被引:0
作者
Richard J. Marszalek
R. John Solaro
Beata M. Wolska
机构
[1] University of Illinois at Chicago,Department of Physiology and Biophysics and the Center for Cardiovascular Research
[2] University of Illinois at Chicago,College of Medicine
[3] University of Illinois at Chicago,Department of Physiology and Biophysics (M/C 901), College of Medicine
[4] University of Illinois at Chicago,Department of Medicine, Division of Cardiology, College of Medicine
来源
Pflügers Archiv - European Journal of Physiology | 2019年 / 471卷
关键词
Hypertrophic cardiomyopathy; Microvascular; Ischemia; Pathogenesis; Energetics;
D O I
暂无
中图分类号
学科分类号
摘要
Alterations in the coronary vascular system are likely associated with a mismatch between energy demand and energy supply and critical in triggering the cascade of events that leads to symptomatic hypertrophic cardiomyopathy. Targeting the early events, particularly vascular remodeling, may be a key approach to developing effective treatments. Improvement in our understanding of hypertrophic cardiomyopathy began with the results of early biophysical studies, proceeded to genetic analyses pinpointing the mutational origin, and now pertains to imaging of the metabolic and flow-related consequences of such mutations. Microvascular dysfunction has been an ongoing hot topic in the imaging of genetic cardiomyopathies marked by its histologically significant remodeling and has proven to be a powerful asset in determining prognosis for these patients as well as enlightening scientists on a potential pathophysiological cascade that may begin early during the developmental process. Here, we discuss questions that continue to remain on the mechanistic processes leading to microvascular dysfunction, its correlation to the morphological changes in the vessels, and its contribution to disease progression.
引用
收藏
页码:769 / 780
页数:11
相关论文
共 50 条
[41]   NONINVASIVE IDENTIFICATION OF LIMITED CORONARY FLOW RESERVE IN HYPERTROPHIC CARDIOMYOPATHY [J].
CAMICI, PG ;
CHIRIATTI, G ;
PICANO, E ;
GISTRI, R ;
LORENZONI, R ;
GIGLI, G ;
SALVADORI, PA ;
CHIARELLA, F ;
NISTA, N ;
PAPI, L ;
LABBATE, A .
CORONARY ARTERY DISEASE, 1992, 3 (06) :513-521
[42]   Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy [J].
Schuldt, Maike ;
van Driel, Beau ;
Alguel, Sila ;
Parbhudayal, Rahana Y. ;
Barge-Schaapveld, Daniela Q. C. M. ;
Gueclue, Ahmet ;
Jansen, Mark ;
Michels, Michelle ;
Baas, Annette F. ;
van de Wiel, Mark A. ;
Nieuwdorp, Max ;
Levin, Evgeni ;
Germans, Tjeerd ;
Jans, Judith J. M. ;
van der Velden, Jolanda .
CELLS, 2021, 10 (11)
[43]   An overview of the treatments for hypertrophic cardiomyopathy [J].
Xu, Wenna ;
Zhu, Fuyu ;
Zhang, Yue ;
Li, Peng ;
Sheng, Yanhui .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
[44]   Hypertrophic cardiomyopathy [J].
Kuehl, Constantin ;
Frey, Norbert .
MEDIZINISCHE GENETIK, 2017, 29 (03) :316-322
[45]   Hypertrophic Cardiomyopathy [J].
Charron, Philippe .
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2017, 201 (4-6) :799-808
[46]   Hypertrophic cardiomyopathy [J].
Santos Mateo, Juan Jose ;
Sabater Molina, Maria ;
Gimeno Blanes, Juan Ramon .
MEDICINA CLINICA, 2018, 150 (11) :434-442
[47]   Hypertrophic Cardiomyopathy [J].
Elijah R. Behr ;
William J. McKenna .
Current Treatment Options in Cardiovascular Medicine, 2002, 4 (6) :443-453
[48]   Hypertrophic Cardiomyopathy [J].
Subasic, Kim .
NURSING CLINICS OF NORTH AMERICA, 2013, 48 (04) :571-+
[49]   Hypertrophic Cardiomyopathy [J].
Dungu, Jason N. ;
Hardy-Wallace, Amy ;
Dimarco, Anthony D. ;
Savage, Henry O. .
CURRENT HEART FAILURE REPORTS, 2024, 21 (04) :428-438
[50]   Hypertrophic cardiomyopathy [J].
John T. Barron .
Current Treatment Options in Cardiovascular Medicine, 1999, 1 (3) :277-282